AU2002222465A1 - Oxidation of dangerous chemical and biological substances - Google Patents
Oxidation of dangerous chemical and biological substancesInfo
- Publication number
- AU2002222465A1 AU2002222465A1 AU2002222465A AU2246502A AU2002222465A1 AU 2002222465 A1 AU2002222465 A1 AU 2002222465A1 AU 2002222465 A AU2002222465 A AU 2002222465A AU 2246502 A AU2246502 A AU 2246502A AU 2002222465 A1 AU2002222465 A1 AU 2002222465A1
- Authority
- AU
- Australia
- Prior art keywords
- catalytic
- triggering
- present
- sterilizing
- light
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000126 substance Substances 0.000 title claims description 97
- 238000007254 oxidation reaction Methods 0.000 title claims description 44
- 230000003647 oxidation Effects 0.000 title claims description 43
- 238000000034 method Methods 0.000 claims description 436
- 230000001954 sterilising effect Effects 0.000 claims description 158
- 241000894007 species Species 0.000 claims description 149
- 230000001473 noxious effect Effects 0.000 claims description 127
- 238000004659 sterilization and disinfection Methods 0.000 claims description 113
- 230000003197 catalytic effect Effects 0.000 claims description 100
- 239000007789 gas Substances 0.000 claims description 98
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 95
- 229910001868 water Inorganic materials 0.000 claims description 94
- 238000011282 treatment Methods 0.000 claims description 89
- 239000007788 liquid Substances 0.000 claims description 84
- 150000001875 compounds Chemical class 0.000 claims description 83
- 239000001301 oxygen Substances 0.000 claims description 65
- 229910052760 oxygen Inorganic materials 0.000 claims description 65
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 64
- 230000000249 desinfective effect Effects 0.000 claims description 56
- 230000003213 activating effect Effects 0.000 claims description 52
- 231100000331 toxic Toxicity 0.000 claims description 52
- 230000002588 toxic effect Effects 0.000 claims description 52
- 238000004381 surface treatment Methods 0.000 claims description 51
- 239000000725 suspension Substances 0.000 claims description 50
- 229920002125 Sokalan® Polymers 0.000 claims description 49
- 239000002245 particle Substances 0.000 claims description 49
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 48
- 229960001631 carbomer Drugs 0.000 claims description 47
- 239000000306 component Substances 0.000 claims description 45
- 230000008878 coupling Effects 0.000 claims description 45
- 238000010168 coupling process Methods 0.000 claims description 45
- 238000005859 coupling reaction Methods 0.000 claims description 45
- 230000001965 increasing effect Effects 0.000 claims description 43
- 230000001699 photocatalysis Effects 0.000 claims description 41
- 230000003287 optical effect Effects 0.000 claims description 40
- 230000036541 health Effects 0.000 claims description 38
- 230000005855 radiation Effects 0.000 claims description 37
- 230000009467 reduction Effects 0.000 claims description 37
- 239000007921 spray Substances 0.000 claims description 34
- 230000009286 beneficial effect Effects 0.000 claims description 33
- 238000005516 engineering process Methods 0.000 claims description 32
- 230000008569 process Effects 0.000 claims description 30
- 239000000499 gel Substances 0.000 claims description 27
- 238000004904 shortening Methods 0.000 claims description 27
- 230000001225 therapeutic effect Effects 0.000 claims description 27
- 238000004806 packaging method and process Methods 0.000 claims description 25
- 239000007800 oxidant agent Substances 0.000 claims description 24
- 239000000463 material Substances 0.000 claims description 23
- 239000000427 antigen Substances 0.000 claims description 21
- 210000004369 blood Anatomy 0.000 claims description 21
- 239000008280 blood Substances 0.000 claims description 21
- 238000004519 manufacturing process Methods 0.000 claims description 21
- 239000007787 solid Substances 0.000 claims description 21
- 241000894006 Bacteria Species 0.000 claims description 20
- 108091007433 antigens Proteins 0.000 claims description 20
- 102000036639 antigens Human genes 0.000 claims description 20
- 230000000694 effects Effects 0.000 claims description 19
- 238000010521 absorption reaction Methods 0.000 claims description 18
- 208000015181 infectious disease Diseases 0.000 claims description 18
- 241000700605 Viruses Species 0.000 claims description 17
- 150000003254 radicals Chemical class 0.000 claims description 17
- 230000015572 biosynthetic process Effects 0.000 claims description 16
- 230000002779 inactivation Effects 0.000 claims description 16
- 239000013307 optical fiber Substances 0.000 claims description 16
- 241000282414 Homo sapiens Species 0.000 claims description 15
- 239000000835 fiber Substances 0.000 claims description 15
- 239000004065 semiconductor Substances 0.000 claims description 15
- -1 Polybutylen Polymers 0.000 claims description 14
- 238000004140 cleaning Methods 0.000 claims description 14
- 230000003595 spectral effect Effects 0.000 claims description 14
- 230000004913 activation Effects 0.000 claims description 13
- 238000010494 dissociation reaction Methods 0.000 claims description 13
- 230000005593 dissociations Effects 0.000 claims description 13
- 239000003574 free electron Substances 0.000 claims description 13
- 229920000642 polymer Polymers 0.000 claims description 13
- 230000006378 damage Effects 0.000 claims description 12
- 239000000606 toothpaste Substances 0.000 claims description 12
- 229940034610 toothpaste Drugs 0.000 claims description 12
- 241001465754 Metazoa Species 0.000 claims description 11
- 238000009826 distribution Methods 0.000 claims description 11
- 239000011521 glass Substances 0.000 claims description 11
- 230000003993 interaction Effects 0.000 claims description 11
- 239000000047 product Substances 0.000 claims description 11
- 208000027418 Wounds and injury Diseases 0.000 claims description 10
- 230000008901 benefit Effects 0.000 claims description 10
- 210000001124 body fluid Anatomy 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 230000000415 inactivating effect Effects 0.000 claims description 10
- 230000002458 infectious effect Effects 0.000 claims description 10
- 230000001960 triggered effect Effects 0.000 claims description 10
- 239000004952 Polyamide Substances 0.000 claims description 9
- 239000003086 colorant Substances 0.000 claims description 9
- 229920002647 polyamide Polymers 0.000 claims description 9
- 229920000515 polycarbonate Polymers 0.000 claims description 9
- 239000004417 polycarbonate Substances 0.000 claims description 9
- 229920000728 polyester Polymers 0.000 claims description 9
- 229920006149 polyester-amide block copolymer Polymers 0.000 claims description 9
- 229920000098 polyolefin Polymers 0.000 claims description 9
- 230000003389 potentiating effect Effects 0.000 claims description 9
- QEVHRUUCFGRFIF-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C(C5=CC=C(OC)C=C5N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 QEVHRUUCFGRFIF-MDEJGZGSSA-N 0.000 claims description 9
- 238000005507 spraying Methods 0.000 claims description 9
- 206010052428 Wound Diseases 0.000 claims description 8
- 238000001720 action spectrum Methods 0.000 claims description 8
- 239000013078 crystal Substances 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 230000004044 response Effects 0.000 claims description 8
- 239000010409 thin film Substances 0.000 claims description 8
- 239000012498 ultrapure water Substances 0.000 claims description 8
- 230000005540 biological transmission Effects 0.000 claims description 7
- 208000031513 cyst Diseases 0.000 claims description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 7
- 230000005284 excitation Effects 0.000 claims description 7
- 239000006072 paste Substances 0.000 claims description 7
- 238000012545 processing Methods 0.000 claims description 7
- 238000006862 quantum yield reaction Methods 0.000 claims description 7
- 239000003440 toxic substance Substances 0.000 claims description 7
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 7
- 238000009303 advanced oxidation process reaction Methods 0.000 claims description 6
- 230000004888 barrier function Effects 0.000 claims description 6
- 210000004204 blood vessel Anatomy 0.000 claims description 6
- 239000007767 bonding agent Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 238000004891 communication Methods 0.000 claims description 6
- 238000013329 compounding Methods 0.000 claims description 6
- 238000011109 contamination Methods 0.000 claims description 6
- 238000002405 diagnostic procedure Methods 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 6
- 230000002708 enhancing effect Effects 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 6
- 230000002452 interceptive effect Effects 0.000 claims description 6
- 238000012544 monitoring process Methods 0.000 claims description 6
- 230000035515 penetration Effects 0.000 claims description 6
- 238000005498 polishing Methods 0.000 claims description 6
- 238000002604 ultrasonography Methods 0.000 claims description 6
- 206010028980 Neoplasm Diseases 0.000 claims description 5
- 235000013361 beverage Nutrition 0.000 claims description 5
- 230000017531 blood circulation Effects 0.000 claims description 5
- 231100000481 chemical toxicant Toxicity 0.000 claims description 5
- 231100000673 dose–response relationship Toxicity 0.000 claims description 5
- 239000004021 humic acid Substances 0.000 claims description 5
- 231100000252 nontoxic Toxicity 0.000 claims description 5
- 230000003000 nontoxic effect Effects 0.000 claims description 5
- 230000001590 oxidative effect Effects 0.000 claims description 5
- 230000036961 partial effect Effects 0.000 claims description 5
- 239000011941 photocatalyst Substances 0.000 claims description 5
- 230000000306 recurrent effect Effects 0.000 claims description 5
- 230000035943 smell Effects 0.000 claims description 5
- 239000003643 water by type Substances 0.000 claims description 5
- 239000004698 Polyethylene Substances 0.000 claims description 4
- 201000011510 cancer Diseases 0.000 claims description 4
- 238000006555 catalytic reaction Methods 0.000 claims description 4
- 230000006835 compression Effects 0.000 claims description 4
- 238000007906 compression Methods 0.000 claims description 4
- 239000002537 cosmetic Substances 0.000 claims description 4
- 238000012864 cross contamination Methods 0.000 claims description 4
- 230000001186 cumulative effect Effects 0.000 claims description 4
- 238000005538 encapsulation Methods 0.000 claims description 4
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 claims description 4
- 230000010354 integration Effects 0.000 claims description 4
- 230000001678 irradiating effect Effects 0.000 claims description 4
- 239000006193 liquid solution Substances 0.000 claims description 4
- 239000003550 marker Substances 0.000 claims description 4
- 239000005022 packaging material Substances 0.000 claims description 4
- 229920000573 polyethylene Polymers 0.000 claims description 4
- 229920005644 polyethylene terephthalate glycol copolymer Polymers 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 102000004877 Insulin Human genes 0.000 claims description 3
- 108090001061 Insulin Proteins 0.000 claims description 3
- 238000003491 array Methods 0.000 claims description 3
- 230000001680 brushing effect Effects 0.000 claims description 3
- 239000007799 cork Substances 0.000 claims description 3
- 125000004122 cyclic group Chemical group 0.000 claims description 3
- 238000010894 electron beam technology Methods 0.000 claims description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 230000000977 initiatory effect Effects 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 229940125396 insulin Drugs 0.000 claims description 3
- 239000011707 mineral Substances 0.000 claims description 3
- 210000003739 neck Anatomy 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 3
- 230000000149 penetrating effect Effects 0.000 claims description 3
- 238000003908 quality control method Methods 0.000 claims description 3
- 239000000376 reactant Substances 0.000 claims description 3
- 238000004611 spectroscopical analysis Methods 0.000 claims description 3
- 230000003068 static effect Effects 0.000 claims description 3
- 238000001356 surgical procedure Methods 0.000 claims description 3
- 235000019640 taste Nutrition 0.000 claims description 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 2
- 239000012503 blood component Substances 0.000 claims description 2
- 239000004744 fabric Substances 0.000 claims description 2
- 238000009396 hybridization Methods 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 238000007726 management method Methods 0.000 claims description 2
- 238000002483 medication Methods 0.000 claims description 2
- 230000001089 mineralizing effect Effects 0.000 claims description 2
- 230000001052 transient effect Effects 0.000 claims description 2
- 238000012795 verification Methods 0.000 claims description 2
- 230000000063 preceeding effect Effects 0.000 claims 43
- 239000003381 stabilizer Substances 0.000 claims 3
- 210000001015 abdomen Anatomy 0.000 claims 2
- 238000000862 absorption spectrum Methods 0.000 claims 2
- 238000002316 cosmetic surgery Methods 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 210000002683 foot Anatomy 0.000 claims 2
- 210000004247 hand Anatomy 0.000 claims 2
- 210000003128 head Anatomy 0.000 claims 2
- 210000002414 leg Anatomy 0.000 claims 2
- 210000000664 rectum Anatomy 0.000 claims 2
- 210000000707 wrist Anatomy 0.000 claims 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims 1
- 208000018035 Dental disease Diseases 0.000 claims 1
- 235000006679 Mentha X verticillata Nutrition 0.000 claims 1
- 235000002899 Mentha suaveolens Nutrition 0.000 claims 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims 1
- GIYXAJPCNFJEHY-UHFFFAOYSA-N N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]-1-propanamine hydrochloride (1:1) Chemical compound Cl.C=1C=CC=CC=1C(CCNC)OC1=CC=C(C(F)(F)F)C=C1 GIYXAJPCNFJEHY-UHFFFAOYSA-N 0.000 claims 1
- 239000004677 Nylon Substances 0.000 claims 1
- 230000002009 allergenic effect Effects 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 229920000249 biocompatible polymer Polymers 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 230000000747 cardiac effect Effects 0.000 claims 1
- 238000013132 cardiothoracic surgery Methods 0.000 claims 1
- 239000012707 chemical precursor Substances 0.000 claims 1
- 230000003749 cleanliness Effects 0.000 claims 1
- 229920001577 copolymer Polymers 0.000 claims 1
- 238000005202 decontamination Methods 0.000 claims 1
- 230000003588 decontaminative effect Effects 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 229910001882 dioxygen Inorganic materials 0.000 claims 1
- 230000008030 elimination Effects 0.000 claims 1
- 238000003379 elimination reaction Methods 0.000 claims 1
- 229940124645 emergency medicine Drugs 0.000 claims 1
- 238000002674 endoscopic surgery Methods 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000019634 flavors Nutrition 0.000 claims 1
- 238000002682 general surgery Methods 0.000 claims 1
- 230000000873 masking effect Effects 0.000 claims 1
- 230000005012 migration Effects 0.000 claims 1
- 238000013508 migration Methods 0.000 claims 1
- 208000030194 mouth disease Diseases 0.000 claims 1
- 229920001778 nylon Polymers 0.000 claims 1
- 230000000399 orthopedic effect Effects 0.000 claims 1
- 230000007170 pathology Effects 0.000 claims 1
- 150000002978 peroxides Chemical class 0.000 claims 1
- 238000000554 physical therapy Methods 0.000 claims 1
- 230000000241 respiratory effect Effects 0.000 claims 1
- 230000000451 tissue damage Effects 0.000 claims 1
- 231100000827 tissue damage Toxicity 0.000 claims 1
- 231100000027 toxicology Toxicity 0.000 claims 1
- 230000002792 vascular Effects 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 35
- 210000001519 tissue Anatomy 0.000 description 20
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 16
- 108090000623 proteins and genes Proteins 0.000 description 14
- 229920002477 rna polymer Polymers 0.000 description 14
- 210000001744 T-lymphocyte Anatomy 0.000 description 13
- 230000001427 coherent effect Effects 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 12
- 102000053602 DNA Human genes 0.000 description 12
- 230000028993 immune response Effects 0.000 description 12
- 210000000265 leukocyte Anatomy 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 11
- 210000000987 immune system Anatomy 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 10
- 238000007146 photocatalysis Methods 0.000 description 9
- 206010020751 Hypersensitivity Diseases 0.000 description 8
- 230000009471 action Effects 0.000 description 8
- 229910052786 argon Inorganic materials 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 229910052743 krypton Inorganic materials 0.000 description 8
- DNNSSWSSYDEUBZ-UHFFFAOYSA-N krypton atom Chemical compound [Kr] DNNSSWSSYDEUBZ-UHFFFAOYSA-N 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 8
- 125000004429 atom Chemical group 0.000 description 7
- 230000004907 flux Effects 0.000 description 7
- 230000007124 immune defense Effects 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 7
- 230000010076 replication Effects 0.000 description 7
- 102000008072 Lymphokines Human genes 0.000 description 6
- 108010074338 Lymphokines Proteins 0.000 description 6
- 210000003719 b-lymphocyte Anatomy 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 239000000645 desinfectant Substances 0.000 description 6
- 230000007613 environmental effect Effects 0.000 description 6
- 210000002865 immune cell Anatomy 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 6
- 210000004698 lymphocyte Anatomy 0.000 description 6
- 210000005210 lymphoid organ Anatomy 0.000 description 6
- 210000002540 macrophage Anatomy 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 229910052753 mercury Inorganic materials 0.000 description 6
- 238000000576 coating method Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 238000005086 pumping Methods 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical group O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 230000007815 allergy Effects 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 210000000612 antigen-presenting cell Anatomy 0.000 description 4
- 210000001185 bone marrow Anatomy 0.000 description 4
- 230000002860 competitive effect Effects 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 230000005283 ground state Effects 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 238000009434 installation Methods 0.000 description 4
- 230000002045 lasting effect Effects 0.000 description 4
- 210000001165 lymph node Anatomy 0.000 description 4
- 210000001365 lymphatic vessel Anatomy 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 230000010287 polarization Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 230000032258 transport Effects 0.000 description 4
- 229960005486 vaccine Drugs 0.000 description 4
- 238000003466 welding Methods 0.000 description 4
- 239000002028 Biomass Substances 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 108010044091 Globulins Proteins 0.000 description 3
- 102000006395 Globulins Human genes 0.000 description 3
- 102000013967 Monokines Human genes 0.000 description 3
- 108010050619 Monokines Proteins 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 208000030961 allergic reaction Diseases 0.000 description 3
- 210000003651 basophil Anatomy 0.000 description 3
- 238000005452 bending Methods 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 239000010836 blood and blood product Substances 0.000 description 3
- 210000000601 blood cell Anatomy 0.000 description 3
- 229940125691 blood product Drugs 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000009501 film coating Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000002070 germicidal effect Effects 0.000 description 3
- 210000003714 granulocyte Anatomy 0.000 description 3
- 230000009931 harmful effect Effects 0.000 description 3
- CPBQJMYROZQQJC-UHFFFAOYSA-N helium neon Chemical compound [He].[Ne] CPBQJMYROZQQJC-UHFFFAOYSA-N 0.000 description 3
- 210000003630 histaminocyte Anatomy 0.000 description 3
- 210000005260 human cell Anatomy 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 210000002751 lymph Anatomy 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 210000001616 monocyte Anatomy 0.000 description 3
- 210000001539 phagocyte Anatomy 0.000 description 3
- 238000006303 photolysis reaction Methods 0.000 description 3
- 210000004180 plasmocyte Anatomy 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 238000002834 transmittance Methods 0.000 description 3
- 208000030507 AIDS Diseases 0.000 description 2
- 241001076960 Argon Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 208000034656 Contusions Diseases 0.000 description 2
- 206010011968 Decreased immune responsiveness Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000009329 Graft vs Host Disease Diseases 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 2
- 229910052779 Neodymium Inorganic materials 0.000 description 2
- 239000003570 air Substances 0.000 description 2
- 235000013876 argon Nutrition 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 210000003855 cell nucleus Anatomy 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 230000001066 destructive effect Effects 0.000 description 2
- 238000005553 drilling Methods 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 210000003979 eosinophil Anatomy 0.000 description 2
- 230000005281 excited state Effects 0.000 description 2
- 208000024908 graft versus host disease Diseases 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000004408 hybridoma Anatomy 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000005865 ionizing radiation Effects 0.000 description 2
- 210000003563 lymphoid tissue Anatomy 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 239000008239 natural water Substances 0.000 description 2
- QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 description 2
- 229910052754 neon Inorganic materials 0.000 description 2
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 2
- 210000000440 neutrophil Anatomy 0.000 description 2
- 210000004940 nucleus Anatomy 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 238000010895 photoacoustic effect Methods 0.000 description 2
- 238000006552 photochemical reaction Methods 0.000 description 2
- 230000015843 photosynthesis, light reaction Effects 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000007420 reactivation Effects 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 210000003171 tumor-infiltrating lymphocyte Anatomy 0.000 description 2
- 206010068150 Acoustic shock Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 231100000699 Bacterial toxin Toxicity 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102000000989 Complement System Proteins Human genes 0.000 description 1
- 108010069112 Complement System Proteins Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 101000702559 Homo sapiens Probable global transcription activator SNF2L2 Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010021460 Immunodeficiency syndromes Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 241000286904 Leptothecata Species 0.000 description 1
- 241001495016 Loriidae Species 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 241000907681 Morpho Species 0.000 description 1
- 208000001388 Opportunistic Infections Diseases 0.000 description 1
- 230000010718 Oxidation Activity Effects 0.000 description 1
- 208000007542 Paresis Diseases 0.000 description 1
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical compound ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 1
- 241000255969 Pieris brassicae Species 0.000 description 1
- 241000221535 Pucciniales Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 238000011579 SCID mouse model Methods 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 230000005867 T cell response Effects 0.000 description 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
- 108010092262 T-Cell Antigen Receptors Proteins 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- 241000221561 Ustilaginales Species 0.000 description 1
- 241001464837 Viridiplantae Species 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000002534 adenoid Anatomy 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- JNDMLEXHDPKVFC-UHFFFAOYSA-N aluminum;oxygen(2-);yttrium(3+) Chemical compound [O-2].[O-2].[O-2].[Al+3].[Y+3] JNDMLEXHDPKVFC-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003460 anti-nuclear Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 210000000628 antibody-producing cell Anatomy 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- WZSUOQDIYKMPMT-UHFFFAOYSA-N argon krypton Chemical compound [Ar].[Kr] WZSUOQDIYKMPMT-UHFFFAOYSA-N 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 239000000688 bacterial toxin Substances 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000012824 chemical production Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 230000024203 complement activation Effects 0.000 description 1
- 230000004154 complement system Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000021554 flavoured beverage Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 210000004754 hybrid cell Anatomy 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 230000002637 immunotoxin Effects 0.000 description 1
- 231100000608 immunotoxin Toxicity 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000000752 ionisation method Methods 0.000 description 1
- 210000001865 kupffer cell Anatomy 0.000 description 1
- 210000001821 langerhans cell Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 210000003810 lymphokine-activated killer cell Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 230000005226 mechanical processes and functions Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000005499 meniscus Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 1
- 108700039855 mouse a Proteins 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229910052756 noble gas Inorganic materials 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000005693 optoelectronics Effects 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 208000012318 pareses Diseases 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000001986 peyer's patch Anatomy 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000010979 ruby Substances 0.000 description 1
- 229910001750 ruby Inorganic materials 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000011009 synthetic ruby Substances 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- 239000000724 thymus hormone Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
- 229910019901 yttrium aluminum garnet Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
- A61L2/088—Radiation using a photocatalyst or photosensitiser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
- A61L2/10—Ultraviolet radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/26—Accessories or devices or components used for biocidal treatment
- A61L2/28—Devices for testing the effectiveness or completeness of sterilisation, e.g. indicators which change colour
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Mathematical Physics (AREA)
- Composite Materials (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Theoretical Computer Science (AREA)
- Biophysics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Materials Engineering (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Physical Water Treatments (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Catalysts (AREA)
- Fire-Extinguishing Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL14018000A IL140180A0 (en) | 2000-12-07 | 2000-12-07 | Advanced oxidation of dangerous chemical and biological sources |
| IL140180 | 2000-12-07 | ||
| PCT/IL2001/001137 WO2002045756A2 (en) | 2000-12-07 | 2001-12-07 | Oxidation of dangerous chemical and biological substances |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002222465A1 true AU2002222465A1 (en) | 2002-06-18 |
Family
ID=11074899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002222465A Abandoned AU2002222465A1 (en) | 2000-12-07 | 2001-12-07 | Oxidation of dangerous chemical and biological substances |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20040120844A1 (pt) |
| EP (1) | EP1343535A2 (pt) |
| JP (1) | JP2004523262A (pt) |
| KR (1) | KR20030077552A (pt) |
| CN (1) | CN1555273A (pt) |
| AU (1) | AU2002222465A1 (pt) |
| BR (1) | BR0116514A (pt) |
| CA (1) | CA2436602A1 (pt) |
| HU (1) | HUP0303488A2 (pt) |
| IL (1) | IL140180A0 (pt) |
| MA (1) | MA25986A1 (pt) |
| MX (1) | MXPA03005118A (pt) |
| NO (1) | NO20032516L (pt) |
| PL (1) | PL365438A1 (pt) |
| RU (1) | RU2003117365A (pt) |
| WO (1) | WO2002045756A2 (pt) |
| ZA (1) | ZA200304400B (pt) |
Families Citing this family (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2467824C (en) * | 2001-11-01 | 2012-06-05 | Intecon Systems, Inc. | Denaturing of a biochemical agent using an activated cleaning fluid mist |
| IL157229A (en) | 2003-08-04 | 2006-08-20 | Zamir Tribelsky | Method for energy coupling especially useful for disinfecting and various systems using it |
| US11246951B2 (en) | 2005-01-31 | 2022-02-15 | S. Edward Neister | Method and apparatus for sterilizing and disinfecting air and surfaces and protecting a zone from external microbial contamination |
| ES2437204T3 (es) * | 2005-01-31 | 2014-01-09 | S. Edward Neister | Procedimiento y aparato para esterilizar y desinfectar aire y superficies, y proteger una zona frente a la contaminación microbiana externa |
| JP4880690B2 (ja) | 2005-06-21 | 2012-02-22 | ルミムーブ・インコーポレーテッド・ディー／ビー／エイ・クロスリンク・ポリマー・リサーチ | 信号活性汚染除去コーティング |
| US8758679B2 (en) * | 2006-03-31 | 2014-06-24 | The Invention Science Fund I, Llc | Surveying sterilizer methods and systems |
| US20090232703A1 (en) | 2006-03-31 | 2009-09-17 | Searete Llc | Methods and systems for monitoring sterilization status |
| US8932535B2 (en) | 2006-03-31 | 2015-01-13 | The Invention Science Fund I, Llc | Surveying sterilizer methods and systems |
| US8114342B2 (en) * | 2006-03-31 | 2012-02-14 | The Invention Science Fund I, Llc | Methods and systems for monitoring sterilization status |
| US20070231193A1 (en) * | 2006-03-31 | 2007-10-04 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Sterilization methods and systems |
| US20110064605A1 (en) * | 2006-07-05 | 2011-03-17 | Thermapure, Inc. | Method for treating an object contaminated with harmful biological organisms or chemical substances utilizing electromagnetic waves |
| US8652040B2 (en) | 2006-12-19 | 2014-02-18 | Valencell, Inc. | Telemetric apparatus for health and environmental monitoring |
| US8157730B2 (en) * | 2006-12-19 | 2012-04-17 | Valencell, Inc. | Physiological and environmental monitoring systems and methods |
| US8323982B2 (en) * | 2007-01-11 | 2012-12-04 | Valencell, Inc. | Photoelectrocatalytic fluid analyte sensors and methods of fabricating and using same |
| GB0718721D0 (en) | 2007-09-25 | 2007-11-07 | Medical Device Innovations Ltd | Surgical resection apparatus |
| US8251903B2 (en) | 2007-10-25 | 2012-08-28 | Valencell, Inc. | Noninvasive physiological analysis using excitation-sensor modules and related devices and methods |
| US8696997B2 (en) | 2007-11-06 | 2014-04-15 | Creo Medical Limited | Hydroxyl radical producing plasma sterilisation apparatus |
| CN104174049B (zh) | 2007-11-06 | 2017-03-01 | 克里奥医药有限公司 | 可调施放器组件以及等离子体灭菌设备 |
| US9750462B2 (en) | 2009-02-25 | 2017-09-05 | Valencell, Inc. | Monitoring apparatus and methods for measuring physiological and/or environmental conditions |
| US8788002B2 (en) | 2009-02-25 | 2014-07-22 | Valencell, Inc. | Light-guiding devices and monitoring devices incorporating same |
| EP3357419A1 (en) | 2009-02-25 | 2018-08-08 | Valencell, Inc. | Light-guiding devices and monitoring devices incorporating same |
| RU2396092C1 (ru) * | 2009-05-20 | 2010-08-10 | Яков Абраммерович Гольдштейн | Установка для обеззараживания воздуха |
| CN101780999B (zh) * | 2009-12-17 | 2012-10-17 | 上海海事大学 | 放电雾化和催化协同水处理法 |
| EP2523693A4 (en) * | 2010-01-14 | 2017-05-31 | Infection Prevention Technologies | Systems and methods for emitting radiant energy |
| WO2011143265A2 (en) | 2010-05-10 | 2011-11-17 | Ted Cole | Uv germicidal system, method, and device thereof |
| US9974873B2 (en) | 2010-05-10 | 2018-05-22 | Uv Partners, Inc. | UV germicidal system, method, and device thereof |
| CN102240407B (zh) * | 2010-05-13 | 2013-08-07 | 上海佩尼医疗科技发展有限公司 | 一种用于血液净化产品的电子束灭菌方法 |
| US8888701B2 (en) | 2011-01-27 | 2014-11-18 | Valencell, Inc. | Apparatus and methods for monitoring physiological data during environmental interference |
| WO2013016007A2 (en) | 2011-07-25 | 2013-01-31 | Valencell, Inc. | Apparatus and methods for estimating time-state physiological parameters |
| US9801552B2 (en) | 2011-08-02 | 2017-10-31 | Valencell, Inc. | Systems and methods for variable filter adjustment by heart rate metric feedback |
| US9046619B2 (en) * | 2011-12-15 | 2015-06-02 | Raytheon Company | Method and apparatus to monitor a beam of ionizing radiation |
| CN110013240A (zh) | 2013-01-28 | 2019-07-16 | 瓦伦赛尔公司 | 具有与身体运动脱开的感测元件的生理监测装置 |
| US10064700B2 (en) * | 2013-02-14 | 2018-09-04 | Zvi Fudim | Surgical guide kit apparatus and method |
| US9339572B2 (en) * | 2013-03-15 | 2016-05-17 | EP Technologies LLC | Methods and solutions for killing or deactivating spores |
| CN104250028A (zh) * | 2013-06-28 | 2014-12-31 | 成都易生玄科技有限公司 | 一种缩聚、传输光线的漱口方法 |
| TWI559942B (en) * | 2013-08-15 | 2016-12-01 | Univ Nat Cheng Kung | Ultraviolet laser sterilization system |
| JP6178197B2 (ja) * | 2013-09-30 | 2017-08-09 | 株式会社東芝 | 放射線検出装置および放射線検出方法 |
| GB201401151D0 (en) * | 2014-01-23 | 2014-03-12 | Linde Ag | Plasma device |
| EP2918294A1 (de) * | 2014-03-11 | 2015-09-16 | Bayer Technology Services GmbH | Vorrichtung und Verfahren zur kontinuierlichen Virusinaktivierung |
| US9538921B2 (en) | 2014-07-30 | 2017-01-10 | Valencell, Inc. | Physiological monitoring devices with adjustable signal analysis and interrogation power and monitoring methods using same |
| EP3151737B1 (en) | 2014-08-06 | 2022-08-17 | Valencell, Inc. | Optical physiological sensor modules with reduced signal noise |
| CA2961224C (en) | 2014-09-18 | 2019-01-22 | Xenex Disinfection Services, Llc. | Room and area disinfection utilizing pulsed light with modulated power flux and light systems with visible light compensation between pulses |
| US9794653B2 (en) | 2014-09-27 | 2017-10-17 | Valencell, Inc. | Methods and apparatus for improving signal quality in wearable biometric monitoring devices |
| KR102362654B1 (ko) | 2015-07-03 | 2022-02-15 | 삼성전자주식회사 | 오븐 |
| CA2993803A1 (en) | 2015-07-28 | 2017-02-02 | EP Technologies LLC | Scrubbing device for cleaning, sanitizing or disinfecting |
| CA2996310A1 (en) | 2015-08-31 | 2017-03-09 | EP Technologies LLC | Generation of antimicrobial wipes using non-thermal plasma |
| US10610158B2 (en) | 2015-10-23 | 2020-04-07 | Valencell, Inc. | Physiological monitoring devices and methods that identify subject activity type |
| US10945618B2 (en) | 2015-10-23 | 2021-03-16 | Valencell, Inc. | Physiological monitoring devices and methods for noise reduction in physiological signals based on subject activity type |
| JP6178392B2 (ja) * | 2015-12-14 | 2017-08-09 | 株式会社トクヤマ | 自動車用空気調和装置 |
| CN105833306B (zh) * | 2016-03-31 | 2018-07-24 | 泰州市海陵区一马商务信息咨询有限公司 | 针对不同人群的细菌浓度超标杀菌系统及其杀菌方法 |
| US9861102B2 (en) | 2016-05-26 | 2018-01-09 | Markesbery Blue Pearl LLC | Methods for disinfection |
| US11425911B2 (en) | 2017-05-25 | 2022-08-30 | Markesbery Blue Pearl LLC | Method for disinfection of items and spaces |
| DE102016008324A1 (de) * | 2016-07-07 | 2018-01-11 | Lengmo Gmbh | Desinfektionsvorrichtung und Desinfektionsverfahren |
| US10966662B2 (en) | 2016-07-08 | 2021-04-06 | Valencell, Inc. | Motion-dependent averaging for physiological metric estimating systems and methods |
| US10232954B2 (en) * | 2016-09-21 | 2019-03-19 | The Boeing Company | Apparatuses and methods for reducing ozone creation from ultraviolet (UV) light |
| US10117319B2 (en) * | 2016-10-21 | 2018-10-30 | Reginald J Exton | Method and system for generating plasma in an atmosphere |
| US10692704B2 (en) | 2016-11-10 | 2020-06-23 | Gojo Industries Inc. | Methods and systems for generating plasma activated liquid |
| TWI617281B (zh) | 2017-01-12 | 2018-03-11 | 財團法人工業技術研究院 | 傷口狀態分析方法與系統 |
| US10942041B2 (en) * | 2018-07-27 | 2021-03-09 | Aurora Flight Sciences Corporation | Chemosensing autonomy system for a vehicle |
| CN109110969B (zh) * | 2018-09-13 | 2021-06-25 | 上海离原环境科技有限公司 | 一种铀矿废水等离子体协同处置方法和系统 |
| ES2906372T3 (es) * | 2018-09-30 | 2022-04-18 | Guangdong Oppo Mobile Telecommunications Corp Ltd | Método y sistema para probar un estado de salida y medio de almacenamiento informático |
| WO2020254557A1 (en) * | 2019-06-19 | 2020-12-24 | Farmer-Light Holding A/S | Method, device and ventilation system for reducing the microbial pressure in an animal farm production facility |
| EP3967998B1 (en) * | 2019-06-25 | 2024-07-31 | Nagano Keiki Co., Ltd. | Optical sensor and physical quantity measurement device |
| CA3169803A1 (en) | 2020-03-06 | 2021-09-10 | Uv Partners, Inc. | Uv disinfection platform |
| US11020502B1 (en) | 2020-05-01 | 2021-06-01 | Uv Innovators, Llc | Ultraviolet (UV) light emission device, and related methods of use, particularly suited for decontamination |
| RU2749992C1 (ru) * | 2020-08-03 | 2021-06-21 | Мацук Игорь Владиславович | Устройство для фотоинактивации патогенных биологических агентов |
| US20220272207A1 (en) * | 2021-02-24 | 2022-08-25 | General Electric Company | Automated beam scan calibration, alignment, and adjustment |
| US12121621B2 (en) | 2021-07-09 | 2024-10-22 | B/E Aerospace, Inc. | Sanitization systems and methods |
| US12060148B2 (en) | 2022-08-16 | 2024-08-13 | Honeywell International Inc. | Ground resonance detection and warning system and method |
| CN118529811B (zh) * | 2024-05-30 | 2024-10-25 | 江苏工程职业技术学院 | 一种适用于污水处理的激光空化装置 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN153503B (pt) * | 1979-01-11 | 1984-07-21 | Nat Res Dev | |
| US4661264A (en) * | 1984-01-16 | 1987-04-28 | Autotrol Corporation | Laser disinfection of liquids |
| AU605129B2 (en) * | 1986-11-13 | 1991-01-10 | Purepulse Technologies, Inc. | Preservation of foodstuffs by irradiation |
| US4744094A (en) * | 1986-12-12 | 1988-05-10 | Zenith Electronics Corporation | BPSK demodulator with D type flip/flop |
| US5298182A (en) * | 1989-01-31 | 1994-03-29 | Ciba-Geigy Corporation | Rapid ophthalmic glycol/lower alkanol cleaning and disinfecting solution and method |
| US5120450A (en) * | 1989-12-27 | 1992-06-09 | Stanley Jr E Glynn | Ultraviolet radiation/oxidant fluid decontamination apparatus |
| US5144146A (en) * | 1990-07-06 | 1992-09-01 | Ultraviolet Energy Generators, Inc. | Method for destruction of toxic substances with ultraviolet radiation |
| DE4032779C2 (de) * | 1990-10-16 | 2000-10-26 | Wolfgang Wiedemann | Zahnbürste zur Feststellung von Zahnbelag |
| US5667733A (en) * | 1992-08-19 | 1997-09-16 | Lowndes Engineering Co., Inc. | Aerosol generator and method for effecting the size of droplets dispersed thereby |
| US5364645A (en) * | 1992-10-30 | 1994-11-15 | The Regents Of The University Of California | Method of controlling microorganisms by pulsed ultraviolet laser radiation |
| DE4307204C2 (de) * | 1993-03-08 | 1995-01-12 | Univ Schiller Jena | Anordnung zur Reinigung von Flüssigkeiten und/oder Gasen |
| DE19628133A1 (de) * | 1996-07-12 | 1998-01-15 | Heraeus Noblelight Gmbh | Verfahren zum Desinfizieren und Reinigen von Kleinteilen und dafür geeignete Vorrichtung |
| CA2307566A1 (en) * | 1997-11-12 | 1999-05-20 | Bausch & Lomb Incorporated | Disinfecting contact lenses with polyquaterniums and polymeric biguanides |
| IL122388A (en) * | 1997-12-01 | 2004-05-12 | Atlantium Lasers Ltd | Method and device for disinfecting liquids or gases |
| US6692694B1 (en) * | 1998-11-09 | 2004-02-17 | Clean Earth Technologies, Llc | Method and apparatus for photosensitized ultraviolet decontamination of surfaces and aerosol clouds |
| CN1255322A (zh) * | 1998-12-02 | 2000-06-07 | 中国科学院光电技术研究所 | 口腔洁净仪及其洁牙膏 |
| AUPP936899A0 (en) * | 1999-03-22 | 1999-04-15 | Combellack, Joseph Henry | Atomising nozzle |
| IL129564A (en) * | 1999-04-23 | 2004-06-20 | Atlantium Lasers Ltd | A method for disinfecting and purifying liquids and gases and a device for its use |
-
2000
- 2000-12-07 IL IL14018000A patent/IL140180A0/xx unknown
-
2001
- 2001-12-07 WO PCT/IL2001/001137 patent/WO2002045756A2/en not_active Application Discontinuation
- 2001-12-07 US US10/433,776 patent/US20040120844A1/en not_active Abandoned
- 2001-12-07 KR KR10-2003-7007666A patent/KR20030077552A/ko not_active Application Discontinuation
- 2001-12-07 CA CA002436602A patent/CA2436602A1/en not_active Abandoned
- 2001-12-07 HU HU0303488A patent/HUP0303488A2/hu unknown
- 2001-12-07 PL PL01365438A patent/PL365438A1/xx unknown
- 2001-12-07 EP EP01999391A patent/EP1343535A2/en not_active Withdrawn
- 2001-12-07 MX MXPA03005118A patent/MXPA03005118A/es unknown
- 2001-12-07 AU AU2002222465A patent/AU2002222465A1/en not_active Abandoned
- 2001-12-07 CN CNA018225381A patent/CN1555273A/zh active Pending
- 2001-12-07 RU RU2003117365/15A patent/RU2003117365A/ru not_active Application Discontinuation
- 2001-12-07 JP JP2002547538A patent/JP2004523262A/ja active Pending
- 2001-12-07 BR BR0116514-3A patent/BR0116514A/pt not_active Application Discontinuation
-
2003
- 2003-06-03 NO NO20032516A patent/NO20032516L/no not_active Application Discontinuation
- 2003-06-05 ZA ZA200304400A patent/ZA200304400B/en unknown
- 2003-06-06 MA MA27196A patent/MA25986A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA03005118A (es) | 2004-10-15 |
| CN1555273A (zh) | 2004-12-15 |
| WO2002045756A3 (en) | 2003-01-03 |
| NO20032516D0 (no) | 2003-06-03 |
| WO2002045756A2 (en) | 2002-06-13 |
| JP2004523262A (ja) | 2004-08-05 |
| MA25986A1 (fr) | 2003-12-31 |
| HUP0303488A2 (hu) | 2004-03-01 |
| PL365438A1 (en) | 2005-01-10 |
| CA2436602A1 (en) | 2002-06-13 |
| RU2003117365A (ru) | 2004-11-27 |
| IL140180A0 (en) | 2002-12-01 |
| ZA200304400B (en) | 2004-07-09 |
| HU0303488D0 (en) | 2003-11-28 |
| US20040120844A1 (en) | 2004-06-24 |
| NO20032516L (no) | 2003-08-04 |
| KR20030077552A (ko) | 2003-10-01 |
| BR0116514A (pt) | 2003-12-23 |
| EP1343535A2 (en) | 2003-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20040120844A1 (en) | Advanced oxidation of dangerous chemical and biological sources | |
| EP1334031B1 (en) | Disinfection through packaging | |
| IL150914A (en) | A method for hydro-optronio photochemical treatment of liquids | |
| US9630022B2 (en) | Plasmonic assisted systems and methods for interior energy-activation from an exterior source | |
| US20030188740A1 (en) | Method for production of enhanced traceable immunizing drinking water and other liquid and gas products, devices for production and use thereof, and use of the enhanced products for immunizing living beings | |
| CN101397156A (zh) | 液体和气体消毒和净化的方法 | |
| JPH11514277A (ja) | 高輝度パルス多色光を用いて微生物を不活化させる改善方法 | |
| JP2001225814A (ja) | プリフォーム殺菌方法及びプリフォーム殺菌装置 | |
| Wende et al. | Cold physical plasma: A short introduction | |
| US20030161756A1 (en) | Microdispersion treatment of a protein or pharmaceutical | |
| JPS60188161A (ja) | 生物学的媒体の処理のためのパルス光による選択的光分解法 |